aser therapy in the management of Type 2 Diabetes Mellitus: a randomized health study
Not Applicable
- Conditions
- Diabetes Mellitus Type 2C18.452.394.750
- Registration Number
- RBR-4cmhfbj
- Lead Sponsor
- niversidade Federal do Maranhão
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Be aged 18 or over; both genders; have a diagnosis of type 2 diabetes mellitus; be being monitored at the Basic Health Units that are part of the study; have preserved cognitive capacity, which will be assessed using the Mini Mental State Examination (MEEN)
Exclusion Criteria
Uncontrolled diabetes, measured at the time of recruitment or via information obtained from the patient;
smoker; alcoholic; insulin therapy; people with neuromuscular or musculoskeletal diseases or conditions that contraindicate photobiomodulation
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We expect to find a reduction in the average values of glycemic markers.
- Secondary Outcome Measures
Name Time Method Information is expected on the effect of modified ILIB on blood metabolism, heart rate, oxygen saturation, pain level and capillary glycemia.